glp-1 headaches GLP-1: Can It Help Headache and Migraine? GLP-1 reduces migraines and joint

Efficacy and tolerability of oral acetylcysteine (Fabrol) in chronic bronchitis: a double-blind placebo controlled study

Exercise, especially HIIT

This is where the divergence between diabetes and obesity indications becomes most pronounced and most consequential

Gulati, M., Dursun, E., Vincent, K

Patients with established cardiovascular disease should receive a pharmacological treatment intensification with an agent that has demonstrated benefit in cardiovascular safety studies: In patients with pre-existing atherosclerotic cardiovascular disease (ASCVD), a GLP-1 receptor agonist, or SGLT-2 inhibitor with characterized cardiovascular safety should be used

JAMA Intern Med 2013;173:534-9.ArticlePubMed 60